OMDA
Omada Health, Inc. Common StockOMDA
OMDA
About: Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
–
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$20
6%
upside
Avg. target
$24
27%
upside
High target
$29
54%
upside
7 analyst ratings
7 positive
100%
0 neutral
0%
0 negative
0%
Evercore ISI Group | 22%upside $23 | Outperform Maintained | 9 Jul 2025 |
JP Morgan Destiny Jackson | 6%upside $20 | Overweight Initiated | 1 Jul 2025 |
Morgan Stanley Craig Hettenbach | 32%upside $25 | Overweight Initiated | 1 Jul 2025 |
Goldman Sachs David Roman | 54%upside $29 | Buy Initiated | 1 Jul 2025 |
Barclays Saket Kalia | 11%upside $21 | Overweight Initiated | 1 Jul 2025 |
Financial journalist opinion
Positive
Seeking Alpha
6 days ago
Omada Health: Long Growth Runway Ahead
I rate Omada Health a buy due to its strong clinical validation, strategic partnerships, and vast untapped market opportunity. OMDA's clinical outcomes, backed by 29 peer-reviewed studies, provide a true moat and credibility with sophisticated buyers like employers and health plans. Strategic partnerships with Cigna and CVS enable rapid scale, lower customer acquisition costs, and improve revenue visibility, accelerating OMDA's growth trajectory.
Neutral
GlobeNewsWire
1 week ago
Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e.
Neutral
GlobeNewsWire
1 month ago
Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks.4 These data suggest that in the real world, factors like non-persistent medication use mean that many who use GLP-1s for weight management may not see the results reflected in clinical trials.
Positive
Seeking Alpha
1 month ago
Omada Health: Helping Patients, Investors As Well?
Omada's IPO impresses with rapid revenue growth and a unique approach to chronic disease management, but the company remains unprofitable. Valuation is stretched at 5-6x sales, especially given continued operating losses and the need to prove sustainable growth. Key risks, other than losses, include reliance on few PBMs, potential engagement/churn issues, and privacy concerns, making the outlook uncertain.
Positive
TechCrunch
1 month ago
Omada Health IPO signals healthier market, avoids ‘down-round' trend
The IPO market is starting to feel healthier.
Positive
Business Insider
1 month ago
Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.
Omada Health just became the second digital health company to IPO this year. The chronic care company saw its shares jump Friday morning by over 38% above its initial price.
Positive
Yahoo Finance
1 month ago
Omada Health IPO: CEO explains why the digital health company went public now
Telehealth provider Omada Health raised $150 million in its IPO as the company makes its public debut on the Nasdaq on Friday. Omada Health CEO Sean Duffy sits down with Yahoo Finance senior health reporter Anjalee Khemlani at the Nasdaq MarketSite to speak more about Omada's approach to treating chronic diseases, like diabetes, and its relationship with patients and pharmaceutical companies.
Positive
Reuters
1 month ago
Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut
Shares of Omada Health rose 21% in their Nasdaq debut on Friday, valuing the virtual chronic care provider at $1.28 billion.
Positive
WSJ
1 month ago
Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest
Omada Health is making its public-market debut, propelled by Americans' renewed focus on how weight affects physical health.
Positive
CNBC Television
1 month ago
Omada Health CEO Sean Duffy on IPO debut: Today is the right moment for us
Sean Duffy, Omada Health co-founder and CEO, joins 'Squawk Box' to discuss the origins of the company, IPO debut, impact of AI, and more.
Charts implemented using Lightweight Charts™